secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001826667-25-000103
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus completes Preferred Stock exchange; 98.82% tendered at 3.3 common shares each
--------------------------------------------------------------------------------

- Approximately 98.82% of outstanding Series A Convertible Preferred Stock (3,551,502 shares) validly tendered in exchange offer.
- Each preferred share exchanged for 3.3 shares of common stock, based on a $4.00 per common share conversion price.
- Amendment to Certificate of Designations filed July 24, 2025, enabling mandatory conversion of remaining preferred shares.
- Settlement of all validly tendered shares expected on or before August 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000103/0001826667-25-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000103/tlsi-20250724.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer